Venous Thromboembolism

Abstract Number: VPB1381

A Case Series In Pregnant Women Receiving Therapeutic LMWH, Is Monitoring Anti-Xa Levels Necessary?

S. Chong¹, P. Liew², V. Selvaratnam³, S. Tan²

Abstract Number: OC 56.1

A Cross-Ancestry Meta-Analysis of Venous Thromboembolism Genetic Associations

F. Thibord¹, D. Klarin², D. Chasman³, M. Teder-Laving⁴, E. Goode⁵, K. Hveem⁶, A. Martinez-Perez⁷, J. Emmerich⁸, X. Jouven⁹, K. Ito¹⁰, G. Cuellar Partida¹¹, J. Haessler¹², J. Hansen¹³, A. van Hylckama Vlieg¹⁴, P. Morange¹⁵, C. Kabrhel¹⁶, D. Tregouet¹⁷, S. Damrauer¹⁸, A. Johnson¹⁹, N. Smith²⁰

Abstract Number: PB0933

A randomized clinical trial to evaluate the effect of rosuvastatin with enoxaparin on circulating tissue factor extracellular vesicles following ovarian cancer surgery

A. Osataphan¹, R. Patell², R. Rosovsky³, P. Elavalakanar¹, A. Bregar⁴, A. Ramos⁴, L. Garrett¹, S. Ren⁵, D. Neuberg⁵, M. Shea¹, J. Zwicker²

Abstract Number: VPB1378

A systematic review of factors associated with non-adherence to the use of coumarin derivatives or direct oral anticoagulants

W. Freitas Nunes De Sousa¹, N. Sernizon Guimarães¹, C. Costa Viana¹, P. Machado¹, A. Fonseca Medeiros¹, M. Sousa Vianna¹, R. Pedra De Souza¹, C. Margotto Bartollo¹, M. Praxedes², M. Parreiras Martins¹

Abstract Number: PB1322

A ten-year Australian experience of splanchnic vein thrombosis

J. Oktaviana¹, B. Lui¹, P. Ho², H. Lim¹

Abstract Number: OC 48.2

A TEN-YEAR REVIEW OF THE IMPACT OF TRANSITION FROM WARFARIN TO DIRECT ORAL ANTICOAGULANT– HAS VTE TREATMENT BECOME SAFER?

B. Lui¹, B. Wee¹, A. Kwok², J. Lai², Z. Khattak³, C. Donarelli³, P. Ho⁴, H. Lim¹

Abstract Number: PB1365

A Tool Integrated in the Electronic Health Record to Guide Proper Decision-Making Regarding Peri-Endoscopic Anticoagulant Use

A. Plender¹, L. Faber², S. Graumans¹

Abstract Number: PB0927

Abelacimab does not influence the effects of two commonly used antiplatelet agents in vitro

Y. Khder¹, S. Cote², P. Hoffmann³, D. Bloomfield⁴

Abstract Number: PB0925

Abelacimab has no effect on platelet aggregation induced by TRAP-6 and collagen

Y. Khder¹, S. Cote², P. Hoffmann³, D. Bloomfield⁴

Abstract Number: VPB1344

ABO blood group and factor viii level as risk factors for idiopathic venous thromboembolism.

A. Diaz¹, M. Vazquez², M. Ordoñez², F. Neria², J. Cachá², M. Gomez²

Abstract Number: VPB1314

ABO blood group as an additional risk factor for venous thromboembolism

E. Ristovska¹, T. Makarovska Bojadjieva¹, S. Useini¹, E. Velkova¹, E. Petkovic¹, V. Dejanova Ilijevska¹, J. Trajkova¹, L. Ismaili², M. Tashkovska³

Abstract Number: PB0447

Adherence and persistence to Direct Oral Anticoagulants (DOACs) in the community following newly diagnosed Venous Thromboembolism (VTE) – a pharmacy-linkage study

C. Dix¹, H. Bortz², M. da Gama³, M. Treloar³, M. Reynolds³, T. Day⁴, H. Tran⁵

Abstract Number: PB0960

Adherence to thrombophilia testing guidelines and accuracy of thrombophilia work-up: a single-center cross sectional study

K. Vrotniakaite-Bajerciene¹, F. Schmidli², K. Jalowiec², H. Broughton², J. Schneider², A. Haynes³, J. Brodard², A. Rovo², J. Kremer Hovinga⁴, A. Angelillo-Scherrer²

Abstract Number: PB0972

Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial

D. Jimenez¹, C. Rodriguez¹, L. Jara-Palomares², E. Tabernero³, A. Tenes¹, S. Gonzalez¹, W. Briceño¹, J. Lobo⁴, R. Morillo¹, B. Bikdeli⁵

Abstract Number: VPB1342

Aetiological profile of inferior veina cava thrombosis

R. Ben Salah¹, F. Mkaouar², o. Frikha², F. Frikha², Z. bAHLOUL³

Abstract Number: OC 32.3

Anti-β2-glycoprotein I antibodies cause activated protein C resistance by interfering with Factor V cleavage at Arginine 506

T. Noordermeer¹, S. Chemlal¹, J. Molhoek², R. Schutgens³, M. Limper⁴, P. de Groot⁵, J. Meijers⁶, R. Urbanus¹

Abstract Number: VPB0944

Anticoagulant associated bleeding risk assessment model for cancer associated thrombosis patients: A systematic review

G. POENOU¹, E. TOLEDANO², H. HELFER³, L. PLAISANCE², e. VERSINI², N. DIAB⁴, S. DJENNAOUI², I. Mahe⁵

Abstract Number: PB0431

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis

M. Candeloro¹, E. Valeriani², M. Monreal³, W. Ageno⁴, N. Riva⁵, R. Lopez Reyes⁶, M. Peris⁷, J. Beyer Westendorf⁸, S. Schulman⁹, V. Rosa¹⁰, J. LÓPEZ-NÚÑEZ¹¹, J. Garcia-Pagan¹², M. Magaz¹², M. Senzolo¹³, A. De Gottardi¹⁴, M. Di Nisio¹⁵

Abstract Number: PB1370

Anticoagulation Control, Outcomes and Associated Factors in Patients Receiving Warfarin in Long-term care in Africa: A Systematic Review

T. Tadesse¹, G. Temesgen², D. Yadeta³, L. Chelkaba², T. Gedif²

Abstract Number: PB0414

Antiphospholipid Syndrome-related Venous Thromboembolism: A Nationwide Study

H. Hwang¹, S. Bang², J. Lee³, S. Kim³, Y. Kim⁴, M. Kim⁵, J. Hong⁶, H. Yhim⁷